OTCMKTS:APLIF Appili Therapeutics (APLIF) Stock Price, News & Analysis $0.03 +0.00 (+15.06%) (As of 09/6/2024 11:17 AM ET) Add Compare Share Share Today's Range$0.03▼$0.0350-Day Range$0.02▼$0.0352-Week Range$0.02▼$0.07Volume10,759 shsAverage Volume163,969 shsMarket Capitalization$3.61 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsHeadlinesShort InterestStock AnalysisChartEarningsHeadlinesShort Interest Get Appili Therapeutics alerts: Email Address Ad Deal MakerThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase, according to the NY Post. With a sky-high 150% turnover rate, the fast food industry is already grappling with labor issues before taking into account these wage hikes. The industry will need a projected 1 million new workers every year through 2032.Learn more about this much-needed advancement and investment opportunity here. About Appili Therapeutics Stock (OTCMKTS:APLIF)Appili Therapeutics Inc., a biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in the infectious disease in Canada. Its anti-infective portfolio includes ATI-1501, a taste-masked liquid oral suspension formulation of an antibiotic, metronidazole; ATI-1801, a novel topical formulation of paromomycin for the treatment of cutaneous leishmaniasis; and ATI-1701 is a live-attenuated vaccine for Francisella tularensis. Appili Therapeutics Inc. was incorporated in 2015 and is headquartered in Halifax, Canada.Read More APLIF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart APLIF Stock News HeadlinesAugust 29, 2024 | americanbankingnews.comAppili Therapeutics Inc. (OTCMKTS:APLIF) Short Interest UpdateAugust 21, 2024 | finanznachrichten.deAppili Therapeutics Inc.: Appili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with AditxtSeptember 7, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.August 21, 2024 | tmcnet.comAditxt Announces Third Amendment to Arrangement Agreement with Appili TherapeuticsAugust 21, 2024 | globenewswire.comAppili Therapeutics Announces Third Amendment to Arrangement Agreement and Provides Updated on Transaction with AditxtAugust 14, 2024 | finanznachrichten.deAppili Therapeutics Inc.: Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025August 13, 2024 | globenewswire.comAppili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2025July 25, 2024 | finance.yahoo.comAditxt Signs Second Amendment to the Arrangement Agreement with Appili Therapeutics, Targeting September 30 Closing of the AcquisitionSeptember 7, 2024 | Weiss Ratings (Ad)Who are Nvidia’s New Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.July 18, 2024 | globenewswire.comAppili Therapeutics Announces Second Amendment to Arrangement AgreementJuly 2, 2024 | globenewswire.comAppili Therapeutics Announces Amendment to Arrangement Agreement and Increase to Bridge LoanJune 25, 2024 | globenewswire.comAppili Therapeutics Reports Fiscal Year 2024 Financial and Operational ResultsApril 27, 2024 | finanznachrichten.deAppili Therapeutics Inc.: Appili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.April 26, 2024 | finance.yahoo.comAppili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.April 26, 2024 | globenewswire.comAppili Therapeutics Announces Additional Bridge Loan from Bloom Burton & Co.April 18, 2024 | finance.yahoo.comAppili Therapeutics Inc. (APLIF)April 4, 2024 | uk.investing.comAditxt to acquire Appili Therapeutics in strategic moveApril 2, 2024 | businesswire.comAditxt Signs a Definitive Agreement to Acquire Appili Therapeutics Inc., Developer of a Biodefense Vaccine Funded by the U.S. Department of Defense (DoD)See More Headlines Receive APLIF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Appili Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/13/2024Today9/07/2024Fiscal Year End3/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical preparations Sub-IndustryN/A Current SymbolOTCMKTS:APLIF CUSIPN/A CIKN/A Webwww.appilitherapeutics.com Phone902-442-4655FaxN/AEmployees8Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.03) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-2,800,000.00 Net Margins-450.64% Pretax Margin-452.87% Return on EquityN/A Return on Assets-193.94% Debt Debt-to-Equity RatioN/A Current Ratio0.46 Quick Ratio0.46 Sales & Book Value Annual Sales$630,000.00 Price / Sales5.74 Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-0.60Miscellaneous Outstanding Shares121,266,000Free Float106,908,000Market Cap$3.61 million OptionableNot Optionable Beta-0.48 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesDr. Donald D. Cilla Jr.M.B.A., Pharmd, CEO, President & DirectorMr. Kenneth G. HowlingChief Financial OfficerDr. Gary S. Nabors Ph.D.Chief Development OfficerKey CompetitorsEterna TherapeuticsNASDAQ:ERNAConduit PharmaceuticalsNASDAQ:CDTTraws PharmaNASDAQ:TRAWOncotelic TherapeuticsOTCMKTS:OTLCVaccinexNASDAQ:VCNXView All Competitors APLIF Stock Analysis - Frequently Asked Questions How have APLIF shares performed this year? Appili Therapeutics' stock was trading at $0.0265 on January 1st, 2024. Since then, APLIF stock has increased by 12.5% and is now trading at $0.0298. View the best growth stocks for 2024 here. How were Appili Therapeutics' earnings last quarter? Appili Therapeutics Inc. (OTCMKTS:APLIF) issued its quarterly earnings data on Tuesday, August, 13th. The company reported ($0.01) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.01). How do I buy shares of Appili Therapeutics? Shares of APLIF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:APLIF) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Appili Therapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Appili Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free APLIF Stock Alerts